MHC class II‐deficient tumor cell lines with a defective expression of the class II transactivator-Reference-Cited by-同舟云学术

MHC class II‐deficient tumor cell lines with a defective expression of the class II transactivator

Published:2002-05 Issue:5 Volume:14 Page:481-491
ISSN:1460-2377
Container-title:International Immunology
language:en
Short-container-title:

Author:

Naves Rodrigo,Lennon Ana Maria,Barbieri Giovanna,Reyes Lilian,Puga Gisella,Salas Laura,Deffrennes Virginie,Rosemblatt Mario,Fellous Marc,Charron Dominique,Alcaïde‐Loridan Catherine,Bono Maria Rosa

Publisher

Oxford University Press (OUP)

Subject

Immunology,General Medicine,Immunology and Allergy

Link

http://academic.oup.com/intimm/article-pdf/14/5/481/18321832/140481.pdf

Reference52 articles.

1. Germain, R. N. 1994. MHC‐dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell76:287.

2. Glimcher, L. H. and Kara, C. J. 1992. Sequences and factors: a guide to MHC class II transcription. Annu. Rev. Immunol.10:13.

3. Reith, W., Muhlethaler‐Mottet, A., Masternak, K., Villard, J. and Mach B. 1999. The molecular basis of MHC class II deficiency and transcriptional control of MHC class II gene expression. Microb. Infect.1:839.

4. Griscelli, C., Lisowska‐Grospierre, B. and Mach B. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev.1:135.

5. Bénichou, B. and Strominger, J. L. 1991. Class II‐antigen‐negative patient and mutant B‐cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc. Natl Acad. Sci. USA88:4285.

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Scanning the Cell Surface Proteome of Cancer Cells and Identification of Metastasis-Associated Proteins Using a Subtractive Immunization Strategy;Journal of Proteome Research;2009-10-01

2. Loss of interferon-γ inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation;British Journal of Dermatology;2008-05

3. Anomalous expression of the HLA-DR alpha and beta chains in ovarian and other cancers;Cancer Biology & Therapy;2004-10

4. Mini-review: Specificity and expression of CIITA, the master regulator of MHC class II genes;European Journal of Immunology;2004-06

5. Cathepsin E: A Novel Target for Regulation by Class II Transactivator;The Journal of Immunology;2004-04-20